1. Every‐other‐day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the “Rete Ematologica Pugliese”
   Nicola Di Renzo et al, 2020, Cancer Medicine CrossRef
2. Efficacy and Safety of 5-Hydroxytryptamine-3 Receptor Antagonists (5-HT3 RAs) for The Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: A Review
   Nisaurrahmah Nisaurrahmah et al, 2021, Journal of Drug Delivery and Therapeutics CrossRef